At ISC 2026, a 20-minute IP-RPLC–UV assay distinguished mRNA capping variants without mass spectrometry, matching a UHPLC–MS reference method.
|Articles|April 19, 2012
- The Column-04-19-2012
- Volume 7
- Issue 8
Strategies for Rapid Chiral HPLC Method Development for Pharmaceutical Analysis
Author(s)Kelly Ke Zhang, Midco Chi-Ying Tsang
Automated column and mobile phase screening is the current trend in the pharmaceutical industry to develop chiral methods. This study presents comprehensive strategies for automated rapid chiral HPLC method development including normal-phase, reversed-phase and polar organic phase separation modes.
Advertisement
Automated column and mobile phase screening is the current trend in the pharmaceutical industry to develop chiral methods. This study presents comprehensive strategies for automated rapid chiral HPLC method development including normal-phase, reversed-phase and polar organic phase separation modes.
Articles in this issue
over 14 years ago
Oil spillover 14 years ago
Autism biomarkersover 14 years ago
High Throughput Microchromatographyover 14 years ago
Organic separationover 14 years ago
Biofuel analysisAdvertisement
Related to this article
Erin Chambers reflects on two leadership philosophies and a personal mantra that have shaped her approach to leading teams.
At ISC 2026, a tailored C4 stationary phase resolved over 30 of 64 possible siRNA diastereomers, aiding characterization of oligonucleotide conjugates.
At ISC 2026, separation science advances included a MEMS gas chromatography column for space missions that raised measured efficiency by up to 74%
Erin Chambers shares her near-term and long-term view of how artificial intelligence will shape the chromatography community.
Advertisement
Advertisement